Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|August 26, 1998
Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancerS A Mehdi, J E Etzell, N B Newman, et al.Journal of Neurosurgery|February 1, 1987
Mixed germ-cell tumor of the pineal region. Case reportS L Graziano, F P Paolozzi, A R Rudolph, et al.Medical and Pediatric Oncology|January 1, 1990
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B StudyS L Graziano, K Lee, K J Propert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of responseRobin T Vollmer, Ramaswamy Govindan, Stephen L Graziano, et al.Cancer|July 1, 1993
A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B studyS L Graziano, J E Herndon, F Richards, et al.Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, A Tatum, J E Herndon, et al.Lung Cancer (Amsterdam, Netherlands)|April 17, 2002
The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancerAjeet Gajra, Arthur H Tatum, Nancy Newman, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901Stephen L Graziano, James E Herndon, Mark A Socinski, et al.Chest|November 21, 1998
Prognostic significance of Lewis y antigen in resected stage I and II non-small cell lung cancerS A Mehdi, A H Tatum, N B Newman, et al.Oncogene Research|January 1, 1988
DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25S L Graziano, G E Mark, C Murray, et al.Pageof 8